In-patient Care for People with COVID-19 and Diabetes in Myanmar

Aye Aye Aung; Ko Ko; Khin Saw Than; Aung Ko Ko; Myo Thet Naing

doi:10.15605/jafes.035.01.08

Authors

Aye Aye Aung University of Medicine, Mandalay
Ko Ko University of Medicine 2, Yangon
Khin Saw Than University of Medicine 1, Yangon
Aung Ko Ko University of Medicine, Mandalay
Myo Thet Naing University of Medicine, Mandalay

DOI:

https://doi.org/10.15605/jafes.035.01.08

Keywords:

recommendations, in-patient, Myanmar

Abstract

These recommendations are synthesized from international references coupled with expert advice from endocrinologists and doctors caring for patients with COVID-19, to help guide physicians in Myanmar in managing persons with diabetes who are admitted.

Downloads

Download data is not yet available.

Author Biographies

Aye Aye Aung, University of Medicine, Mandalay

President, Myanmar Society of Endocrinology and Metabolism

Department of Endocrinology

30th Street, between 73rd and 74th Street, Chan Aye Thar Zan Township,
Mandalay, Myanmar
Tel. No.: +95 92024013
E-mail: profsmaaa@gmail

Ko Ko, University of Medicine 2, Yangon

Department of Endocrinology

Khin Saw Than, University of Medicine 1, Yangon

Department of Endocrinology

Aung Ko Ko, University of Medicine, Mandalay

Department of Medicine

Myo Thet Naing, University of Medicine, Mandalay

Department of Medicine

References

Diabetes UK. COncise adVice on Inpatient Diabetes (COVID: Diabetes): FRONT DOOR GUIDANCE. 2020. Available from https://www.diabetes.org.uk/resources-s3/public/2020-04/COvID_Front_Door_v1.0.pdf.

Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119-31. https://www.ncbi.nlm.nih.gov/pubmed/19429873. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2681039. https://doi.org/10.2337%2Fdc09-9029.

Zhou J, Tan J. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China. Metabolism. 2020;154216. https://www.ncbi.nlm.nih.gov/pubmed/32220612. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102634. https://doi.org/10.1016%2Fj.metabol.2020.154216.

Wang W, Lu J, Gu W, Zhang Y, Liu J, Ning G. Care for diabetes with COVID-19: Advice from China. J Diabetes. 2020;12(5):417-9. https://doi.org/10.1111/1753-0407.13036.

American Diabetes Association. 15. Diabetes care in the hospital: Standards of Medical Care in Diabetes—2019. Diabetes Care. 2019;42(Suppl. 1):S173-81. https://www.ncbi.nlm.nih.gov/pubmed/30559241. https://doi.org/10.2337/dc19-S015.

Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16-38. https://www.ncbi.nlm.nih.gov/pubmed/22223765. https://doi.org/10.1210/jc.2011-2098.

Drucker DJ. Coronavirus infections and type 2 diabetes—shared pathways with therapeutic implications. Endocr Rev. 2020;41(3):bnaa011. https://www.ncbi.nlm.nih.gov/pubmed/32294179. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184382. https://doi.org/10.1210/endrev/bnaa011.